Waaree Renewable Technologies (NSE: WAAREERTL) adds battery storage and solar contracts, but will margins recover?
Read More Pharma Industry News Why Innovent Biologics and SanegeneBio believe IBI3016 could change hypertension treatment Innovent Biologics and SanegeneBio reveal strong Phase 1 data for IBI3016 at AHA 2025. Discover how this RNAi therapy could redefine hypertension treatment. bySrinathNovember 10, 2025